Jefferson Kinney

Founding Chair, Department of Brain Health
Expertise: Behavioral neuroscience, Alzheimer's disease, Schizophrenia, Learning and memory systems

Biography

Jefferson Kinney is the founding chair of the department of brain health in the Kirk Kerkorian School of Medicine at UNLV. Kinney investigates neurodegenerative disorders, including Alzheimer’s disease, vascular dementia, and Parkinson's disease, with a focus on cellular and molecular changes in the brain that underlie these disorders. 

His current work includes investigating the role of several risk factors associated with Alzheimer’s disease and subtle changes in cell function, including interactions between diabetes and inflammation in the brain throughout the onset and progression of the disease. As part of this work, Kinney collaborates with the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. 

Earlier in his career, Kinney completed an Intramural Research Training Fellowship with the National Institute of Mental Health and the Helen Dorris Fellowship in schizophrenia research at The Scripps Research Institute.

Education

  • B.S., Psychology, Colorado State University
  • M.S., Experimental Psychology, Colorado State University
  • Ph.D., Behavioral Neuroscience, Colorado State University

Search For Other Experts On

,

Jefferson Kinney In The News

K.S.N.V. T.V. News 3
More than 250 representatives are coming together to not only network but also share their dedication to find the cure for Alzheimer's. This includes announcing a new partnership with UNLV.
P.B.S.
A blood test for Alzheimer’s Disease a game-changer for patients and their families.
GoToHealth!
Detect Alzheimer's disease early with a groundbreaking blood test that could change the game for millions of people worldwide! This revolutionary diagnostic tool can identify the disease years before symptoms appear, giving patients and their families a head start on treatment and care. The FDA just cleared the first blood test for identifying patients with amyloid pathology associated with Alzheimer’s disease — and part of the research behind its approval was conducted by leading experts at the UNLV Department of Brain Health, with chair and renowned brain health researcher, Jefferson Kinney, PhD, our guest for today’s Show. In this video, we'll dive into the science behind this innovative test, how it works, and what it means for the future of Alzheimer's research and treatment. If you or a loved one is at risk for Alzheimer's, you won't want to miss this!
K.V.V.U. T.V. Fox 5
A new blood test is being called a game changer for helping diagnose Alzheimer’s. The new FDA-approved test, known as Lumipulse, detects the pTau217/Beta Amyloid 42 amyloids plaques in the brain, a hallmark of the disease.

Articles Featuring Jefferson Kinney

From left to right: Dean Marc J. Kahn, Dr. Jefferson Kinney, Dr. Kate Zhong, Dr. Jeffrey Cummings, and Dr. Mark Guadagnoli at the “Brain Health Frontiers: Tackling Alzheimer's Together” panel discussion.
| February 18, 2025

The 'Brain Health Frontiers: Tackling Alzheimer's Together' panel discussion highlighted the revolutionary research the Department of Brain Health is conducting to fight Alzheimer’s disease.

Josh Hawkins, UNLV
| July 3, 2024

News highlights featuring UNLV students and staff who made (refreshing) waves in the headlines.